Roflumilast
Roflumilast is PDE4 inhibitor used for chronic obstructive pulmonary disease.To reduce the risk of COPD exacerbations in patients with severe COPD associated with chronic bronchitis and a history of exacerbations.
Oral; 500mcg per day.
Moderate to severe liver impairement.
Paediatric: Safety and efficacy not established in paediatric group. Pregnancy: Category C. Lactation: Not to be used by lactating mother. Elderly: Use with caution.
Diarrhea, Weight loss, Nausea, Headache, Insomnia, Decreased appetite, Abdominal pain, Rhinitis, Sinusitis, Urinary tract infection, Depression.
Rifampicin, phenobarbital, carbamazepine, erythromycin, ketoconazole, fluvoxamine, enoxacin, cimetidine, oral contraceptives.